CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to enhance tuberculosis treatment by understanding the mechanisms of resistance in Mycobacterium tuberculosis. It focuses on the role of nitric oxide detoxification in the bacterium's latency and seeks to identify new therapeutic targets to improve treatment efficacy.
Tuberculosis is today amongst the major worldwide health threats.
Treatment failure is unfortunately becoming more usual, especially in countries lacking the long and costly treatment adapted to patients.
Thus, tuberculosis causes 2 million deaths every year and latently persists in over 1 billion individuals worldwide.
Current treatments are challenged by multidrug resistant strains, drug side effects, and co-infections.
Therefore, identification of potent, safety antimycobacterial agents is ma…
UNIVERSITAT DE BARCELONA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Argentina, Buenos Aires
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Sheffield
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
